Logo
x

Search category

Subscribe Now

Study

Cardiovascular Systems, Inc. Reports the First Patient Enrollment of Diamondback 360 Peripheral Orbital Atherectomy System in Japan

Cardiovascular Systems, Inc. Reports the First Patient Enrollment of Diamondback 360 Peripheral Orbital Atherectomy System in Japa...

  • January 12, 2023
Elpiscience Partner Compass Report Interim Results of ES104 + Paclitaxel in P-II Study for the Treatment of Biliary Tract Cancers

Elpiscience Partner Compass Report Interim Results of ES104 + Paclitaxel in P-II Study for the Treatment of Biliary Tract Cancers

  • May 9, 2022
Oncolytics Biotech Presents Results of Pelareorep + Bortezomib in P-Ib Study for the Treatment of Multiple Myeloma at the AACR 2022

Oncolytics Biotech Presents Results of Pelareorep + Bortezomib in P-Ib Study for the Treatment of Multiple Myeloma at the AACR 202...

  • March 10, 2022
Tempus Reports Initiation of an Open-Label P-II Study in Collaboration with GSK to Evaluate Zejula (niraparib) to Treat Advanced or Metastatic Solid Tumors

Tempus Reports Initiation of an Open-Label P-II Study in Collaboration with GSK to Evaluate Zejula (niraparib) to Treat Advanced o...

  • January 14, 2022
Jazz Publishes Results of Xywav in P-III Study for the Treatment of Idiopathic Hypersomnia in Lancet Neurology

Jazz Publishes Results of Xywav in P-III Study for the Treatment of Idiopathic Hypersomnia in Lancet Neurology

  • January 6, 2022
Celltrion Reports Results of Herzuma (biosimilar, rastuzumab) + Gedatolisib in P-II Study for the Treatment of Metastatic Breast Cancer

Celltrion Reports Results of Herzuma (biosimilar, rastuzumab) + Gedatolisib in P-II Study for the Treatment of Metastatic Breast C...

  • December 14, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.